CN1491692A - Red medicine thin film coating tablet - Google Patents
Red medicine thin film coating tablet Download PDFInfo
- Publication number
- CN1491692A CN1491692A CNA031337848A CN03133784A CN1491692A CN 1491692 A CN1491692 A CN 1491692A CN A031337848 A CNA031337848 A CN A031337848A CN 03133784 A CN03133784 A CN 03133784A CN 1491692 A CN1491692 A CN 1491692A
- Authority
- CN
- China
- Prior art keywords
- film coating
- thin film
- red
- substrate
- flos carthami
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 34
- 238000009501 film coating Methods 0.000 title claims description 38
- 239000010409 thin film Substances 0.000 title claims description 28
- 238000000576 coating method Methods 0.000 claims abstract description 30
- 239000011248 coating agent Substances 0.000 claims abstract description 24
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 claims abstract description 22
- 238000002360 preparation method Methods 0.000 claims abstract description 22
- 229920001353 Dextrin Polymers 0.000 claims abstract description 14
- 239000004375 Dextrin Substances 0.000 claims abstract description 14
- 235000019425 dextrin Nutrition 0.000 claims abstract description 14
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 9
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 9
- 239000000758 substrate Substances 0.000 claims description 34
- 239000000203 mixture Substances 0.000 claims description 25
- 241000628997 Flos Species 0.000 claims description 20
- 239000000843 powder Substances 0.000 claims description 18
- 239000007888 film coating Substances 0.000 claims description 15
- 239000007921 spray Substances 0.000 claims description 15
- 238000001035 drying Methods 0.000 claims description 13
- 239000002671 adjuvant Substances 0.000 claims description 12
- 238000005516 engineering process Methods 0.000 claims description 12
- 239000008187 granular material Substances 0.000 claims description 12
- 241001489978 Eupolyphaga Species 0.000 claims description 8
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 8
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 claims description 8
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 8
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 8
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 8
- 239000002994 raw material Substances 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 6
- -1 drying Substances 0.000 claims description 6
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 claims description 4
- 229920000623 Cellulose acetate phthalate Polymers 0.000 claims description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 4
- 239000002202 Polyethylene glycol Substances 0.000 claims description 4
- 229940081734 cellulose acetate phthalate Drugs 0.000 claims description 4
- 239000002552 dosage form Substances 0.000 claims description 4
- 229920001223 polyethylene glycol Polymers 0.000 claims description 4
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 4
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 4
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 4
- 239000002002 slurry Substances 0.000 claims description 4
- 230000001954 sterilising effect Effects 0.000 claims description 4
- 238000004659 sterilization and disinfection Methods 0.000 claims description 4
- 229920002472 Starch Polymers 0.000 claims description 3
- 239000008107 starch Substances 0.000 claims description 3
- 235000019698 starch Nutrition 0.000 claims description 3
- 239000004925 Acrylic resin Substances 0.000 claims description 2
- 229920000178 Acrylic resin Polymers 0.000 claims description 2
- 241000736919 Pelodiscus sinensis Species 0.000 claims description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 2
- 235000011132 calcium sulphate Nutrition 0.000 claims 1
- 238000003860 storage Methods 0.000 abstract description 2
- 244000061520 Angelica archangelica Species 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 241000131329 Carabidae Species 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 238000005453 pelletization Methods 0.000 abstract 1
- 238000005507 spraying Methods 0.000 abstract 1
- 239000003826 tablet Substances 0.000 description 22
- 206010013786 Dry skin Diseases 0.000 description 4
- SQFDQLBYJKFDDO-UHFFFAOYSA-K merbromin Chemical compound [Na+].[Na+].C=12C=C(Br)C(=O)C=C2OC=2C([Hg]O)=C([O-])C(Br)=CC=2C=1C1=CC=CC=C1C([O-])=O SQFDQLBYJKFDDO-UHFFFAOYSA-K 0.000 description 4
- 229940008716 mercurochrome Drugs 0.000 description 4
- 238000000034 method Methods 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000005580 one pot reaction Methods 0.000 description 2
- 230000036407 pain Effects 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000007941 film coated tablet Substances 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 239000005022 packaging material Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB031337848A CN100551359C (en) | 2003-07-24 | 2003-07-24 | Red medicine thin film coating tablet |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB031337848A CN100551359C (en) | 2003-07-24 | 2003-07-24 | Red medicine thin film coating tablet |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1491692A true CN1491692A (en) | 2004-04-28 |
CN100551359C CN100551359C (en) | 2009-10-21 |
Family
ID=34239907
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB031337848A Expired - Lifetime CN100551359C (en) | 2003-07-24 | 2003-07-24 | Red medicine thin film coating tablet |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100551359C (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2895744A1 (en) * | 2006-01-05 | 2007-07-06 | Viviane Lab Soc Par Actions Si | Use of a film forming composition comprising a plasticizer for (film)coating a tablet containing plant powder |
CN1332686C (en) * | 2005-09-29 | 2007-08-22 | 沈阳中药制药有限公司 | Chinese medicine for treating tractures and preparation for making plaster thereof |
CN102106784A (en) * | 2009-12-28 | 2011-06-29 | 郑州豫密药业股份有限公司 | Method for coating Chinese medicine pill by film |
GB2595441A (en) * | 2020-04-23 | 2021-12-01 | Wang Lulin | Bone-strengthening pill (BSP) as a dietary supplement to improve blood circulation and strengthen bone and muscle |
-
2003
- 2003-07-24 CN CNB031337848A patent/CN100551359C/en not_active Expired - Lifetime
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1332686C (en) * | 2005-09-29 | 2007-08-22 | 沈阳中药制药有限公司 | Chinese medicine for treating tractures and preparation for making plaster thereof |
FR2895744A1 (en) * | 2006-01-05 | 2007-07-06 | Viviane Lab Soc Par Actions Si | Use of a film forming composition comprising a plasticizer for (film)coating a tablet containing plant powder |
CN102106784A (en) * | 2009-12-28 | 2011-06-29 | 郑州豫密药业股份有限公司 | Method for coating Chinese medicine pill by film |
GB2595441A (en) * | 2020-04-23 | 2021-12-01 | Wang Lulin | Bone-strengthening pill (BSP) as a dietary supplement to improve blood circulation and strengthen bone and muscle |
GB2595441B (en) * | 2020-04-23 | 2022-08-10 | Wang Lulin | Bone-Strengthening Pill (BSP) as a Dietary Supplement to Improve Blood Circulation and Strengthen Bone and Muscle |
Also Published As
Publication number | Publication date |
---|---|
CN100551359C (en) | 2009-10-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1491692A (en) | Red medicine thin film coating tablet | |
CN1368292A (en) | Nano medicing 'Wenzhong Zhixie' and its preparing process | |
CN1368064A (en) | Nano medicine 'yishenbugu' for tonifying kidney and strengthening bone and its preparing process | |
CN1368353A (en) | Nano medicine 'Zibushengfa' and its preparing process | |
CN1368235A (en) | Nano medicine for treating leukoderma and its preparing process | |
CN1364510A (en) | Nano seven ingredient beard beautifying medicine and its preparing method | |
CN1365728A (en) | Nano medicine for treating throat disease and its preparing process | |
CN1362085A (en) | Nano mixed natural indigo medicine and its preparation | |
CN1368203A (en) | Nano medicine 'Zanglian' and its preparing process | |
CN1366895A (en) | Nano supplement both qi and blood preparation medicine and preparation method thereof | |
CN1368244A (en) | Nano universal gynecologic medicine and its preparing process | |
CN1366953A (en) | Nano midday tea preparation medicine and preparation method | |
CN1360921A (en) | Nanometer eyesight improving adhesive rehmannia medicine and its prepn | |
CN1368116A (en) | Nano medicine 'Yangxin Dingji' and its preparing process | |
CN1363311A (en) | Nano medicine 'Kaixiong Shunqi' and its preparing process | |
CN1368184A (en) | Nano medicine 'Shujin Huoluo' and its preparing process | |
CN1362247A (en) | Nano stomach-nourishing medicine of Aucklandiae and Amino and its preparation | |
CN1365717A (en) | Nano medicine 'Jianer Xiaoshi' and its preparing process | |
CN1368324A (en) | Nano medicine 'Zhike' for relieving cough and its preparing process | |
CN1368280A (en) | Nano medicine 'Zhuangyao Jiansheng' and its preparing process | |
CN1366973A (en) | Nano Guishe preparation medicine and preparation method | |
CN1368362A (en) | Nano medicine for treating lumbocrural pain and its preparing process | |
CN1362179A (en) | Nano eight-ingredient medicine and its preparation | |
CN1365685A (en) | Nano medicine for reating bone fracture and injury and its preparing process | |
CN1368356A (en) | Nano medicine 'Tianjingbushen' and its preparing process |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: SHENYANG HONGYAO PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: SHENYANG CHINESE MEDICINE PHARMACEUTICAL CO., LTD. Effective date: 20080307 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20080307 Address after: Liaoning province Shenyang City District City Road No. 2 post encoding: 110044 Applicant after: SHENYANG HONGYAO PHARMACEUTICAL Co.,Ltd. Address before: Liaoning province Shenyang City District City Road No. 2 post encoding: 110044 Applicant before: SHENYANG CHINESE MEDICINE PHAR |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20120110 Address after: 110044 Liaoning Province, Shenyang City District City Road No. 2 Patentee after: SHENYANG HONGYAO PHARMACEUTICAL Co.,Ltd. Address before: 110044 Liaoning Province, Shenyang City District City Road No. 2 Patentee before: SHENYANG HONGYAO PHARMACEUTICAL Co.,Ltd. |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20140506 Address after: 110044 Liaoning Province, Shenyang City District City Road No. 2 Patentee after: SHENYANG HONGYAO GROUP Co.,Ltd. Address before: 110044 Liaoning Province, Shenyang City District City Road No. 2 Patentee before: SHENYANG HONGYAO PHARMACEUTICAL Co.,Ltd. |
|
CX01 | Expiry of patent term | ||
CX01 | Expiry of patent term |
Granted publication date: 20091021 |